Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 60Recruiting 13Active not recruiting 10Unknown 9Not yet recruiting 8Withdrawn 3Terminated 2Enrolling by invitation 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Pancreatic Neoplasms 1Muscular Diseases 1Motor Activity 1Gastric Adenocarcinoma 1Cachexia 1Breast Neoplasms 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Resistance Training × Clear all
NCT05056805 2024-10-26

An Exercise and Nutrition Monitoring Intervention (Pt Pal) for the Improvement of Strength in Patients With Pancreatic or Stomach Cancer Receiving Chemoradiation Therapy Before Surgery, SurgeryStrong Study

M.D. Anderson Cancer Center

Phase NA Withdrawn
Gastrointestinal

Gastric Adenocarcinoma

NCT04449809 2021-06-21

EXERT-BC

Duke University

Phase NA Withdrawn
Breast

Breast Neoplasms, Motor Activity

NCT01395563 2015-03-13

STOPC

German Cancer Research Center

Phase NA Withdrawn
Gastrointestinal

Cachexia, Muscular Diseases, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡